What a GLP-1 weight-loss program includes

A GLP-1 program is follow-up, not a one-time vial

The shot is the center of the plan, not the whole plan. Someone has to review you, change the dose, help when you are nauseated, handle refills, and talk with you at week six. If a clinic only ships a vial, that is a product. If they stay with you through titration and maintenance, that is a program. Beema's live program details and prices are on the medical weight-loss page. This article is the checklist you can use on any clinic, including ours.

This article is educational. It is not Beema's conversion landing page. That page lives at /weight-loss and is titled around provider-guided GLP-1 care. Here the H1 is about program parts so you can audit any clinic, including ours.

Intake is clinical work, not a quiz for ads

A real intake asks about pancreatitis, gallbladder disease, thyroid cancer family history, pregnancy, other medicines, and prior incretin use. It is not a three-question BMI toy. Beema's intake is a questionnaire reviewed by a licensed provider. You cannot chat inside it; questions after payment go through the care team, and you can email support before you pay.

PHI from that questionnaire belongs in the clinical system, not in an ad pixel. Completing intake never guarantees a prescription.

Titration is where programs earn their keep

Incretin labels increase doses slowly to limit gastrointestinal effects. A program watches whether you can eat enough protein, whether you are dehydrated, and whether a pause is wiser than a jump. Pooled STEP analyses showed nausea in a large minority of people on semaglutide 2.4 mg. Pretending everyone 'just pushes through' is not care.

If you already take a GLP-1 elsewhere, a responsible program asks for your current dose instead of restarting at the bottom by default. Final dosing is still the clinician's.

Maintenance is part of the brochure, or it should be

STEP 4 switched some people from semaglutide to placebo and watched weight return. SURMOUNT-4 showed a similar pattern when tirzepatide was withdrawn. A program that only celebrates the first eight weeks is incomplete. Ask how long follow-up lasts and what happens if you want to stop.

How Beema's cash-pay loop is shaped today

Beema Health connects adults in all 50 US states with independently licensed providers. Service is USA only. If treatment is prescribed, compounded semaglutide or compounded tirzepatide may be used when legally available and clinically appropriate. Compounded semaglutide is not FDA-approved and is considered only when legally available and clinically appropriate. Compounded tirzepatide is not FDA-approved and is considered only when legally available and clinically appropriate. Current monthly and multi-month cash-pay figures live on the compounded semaglutide and compounded tirzepatide pages, including a tirzepatide new-patient starter pack path and a semaglutide first-month promo on a three-month plan. This educational article will not invent branded cash prices Beema does not charge.

Included supplies and expedited shipping are part of the listed rate. There is no membership fee stacked on top. Promo codes are one-time and have plan-length rules explained on those pages.

A checklist you can take to any clinic

Who is the licensed prescriber, and in which state are they licensed? Which pharmacy fills? What is the all-in cash price? What is not included? How do you reach someone if you vomit for two days? What is the policy if you are not a candidate? If answers are vague, keep shopping. Beema's live semaglutide and tirzepatide pages exist to make price and process explicit. Start there when you want the commercial details, not here.

• Licensed provider review before any prescription
• Clear compounding vs FDA-approved status
• Follow-up plan for side effects and maintenance

Frequently asked questions

Sources

1. [1] Rubino D, et al. STEP 4: continued weekly semaglutide versus placebo for weight-loss maintenance. JAMA. 2021.
2. [2] Aronne LJ, et al. SURMOUNT-4: continued tirzepatide for maintenance of weight reduction. JAMA. 2024.
3. [3] NIDDK. Prescription medications to treat overweight and obesity (medicines work best with lifestyle support).
4. [4] Wharton S, Calanna S, Davies M, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity. Diabetes, Obesity and Metabolism. 2021.